This press release contains "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectations about timing and execution of anticipated milestones, including the initiation of dosing of FTDC9orf72 patients; the progress of clinical studies and the availability of clinical data from such trials; our Passage Bio Media: Mike Beyer Sam Brown Inc. Healthcare Communications 3 ...